» Authors » Kentaro Hayashida

Kentaro Hayashida

Explore the profile of Kentaro Hayashida including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 298
Citations 2713
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Khalique O, Zaid S, Tang G, Abdel-Wahab M, Akodad M, Bapat V, et al.
J Am Coll Cardiol . 2025 Mar; 85(10):1042-1055. PMID: 40074470
This updated Heart Valve Collaboratory framework addresses the growing concern for transcatheter valve failure (TVF) following transcatheter aortic valve replacement (TAVR). With the increasing volume of redo-TAV and surgical TAV...
2.
Ishizu K, Shirai S, Hayashi M, Morofuji T, Isotani A, Ohno N, et al.
Am J Cardiol . 2025 Mar; PMID: 40064220
Decompensated hemolytic anemia after transcatheter aortic valve implantation (TAVI) requiring specific treatment is rarely encountered in actual clinical practice. Nevertheless, there have been several cases of clinically relevant hemolytic anemia...
3.
Shibata K, Yamamoto M, Kagase A, Tokuda T, Tsunamoto H, Shimura T, et al.
JACC Adv . 2025 Feb; 4(4):101631. PMID: 40010112
Background: Transcatheter edge-to-edge repair (TEER) is used to treat patients with mitral regurgitation (MR). The Geriatric Nutritional Risk Index (GNRI) is a well-known nutritional marker that predicts mortality risk. Objectives:...
4.
Iwata J, Hayashida K, Kajino A, Sakata S, Ryuzaki T, Tsuruta H, et al.
JACC Asia . 2025 Feb; 5(2):315-317. PMID: 39967224
No abstract available.
5.
Tanaka K, Yamaguchi J, Yoshikawa M, Shibahashi E, Otsuki H, Kawamoto T, et al.
JACC Asia . 2025 Feb; 5(2):273-282. PMID: 39967218
Background: Renal impairment is associated with poor clinical outcomes in patients with cardiovascular diseases. Some studies have revealed the impact of renal impairment on the clinical outcomes of patients who...
6.
Okuno T, Izumo M, Takahiko K, Kuwata S, Koga M, Akashi Y, et al.
JACC Asia . 2025 Feb; 5(2):245-254. PMID: 39967214
Background: The 20-mm balloon-expandable transcatheter heart valve (THV) represents the smallest available option for transcatheter aortic valve replacement (TAVR). Its current underutilization stems from concerns regarding prosthesis-patient mismatch, durability, and...
7.
Iwata J, Hayashida K, Arita R, Moriizumi T, Kajino A, Sakata S, et al.
Catheter Cardiovasc Interv . 2025 Feb; PMID: 39898413
Background: Hypoattenuated leaflet thickening (HALT) after transcatheter aortic valve implantation (TAVI) detected on multidetector computed tomography (MDCT) is considered leaflet thrombosis. However, its impact on long-term clinical outcomes remains unclear....
8.
Iwata J, Hayashida K, Kajino A, Sakata S, Imaeda S, Ryuzaki T, et al.
Health Sci Rep . 2025 Feb; 8(2):e70097. PMID: 39897465
Background: The indication of transcatheter aortic valve replacement (TAVR) is becoming more prevalent among younger and lower-risk patients. However, data on the latest intra-annular TAVR devices are limited. This study...
9.
Tanaka S, Imamura T, Fukuda N, Ueno H, Kinugawa K, Sago M, et al.
JACC Asia . 2025 Feb; 5(1):174-186. PMID: 39896245
Background: Left atrial appendage closure (LAAC) has demonstrated favorable outcomes as an alternative to permanent anticoagulation in patients with nonvalvular atrial fibrillation (NVAF). In hemodialysis (HD) patients with NVAF, anticoagulation...
10.
Matsumoto S, Ohno Y, Noda S, Miyamoto J, Kamioka N, Murakami T, et al.
Eur Heart J . 2025 Jan; PMID: 39873695
Background And Aims: The association between periprocedural change in tricuspid regurgitation (TR) and outcomes in patients undergoing mitral transcatheter edge-to-edge repair (M-TEER) is unclear. This study aimed to examine the...